Heart failure (HF) is a clinical syndrome, which is becoming a major public health problem in recent decades, due to its increasing prevalence, especially in the developed countries, mostly due to prolonged lifespan of the general population as well as the increased of HF patients. The HF tre...
Anemia is common in heart failure (HF), but there is controversy regarding its contribution to morbidity and mortality. To examine the association of mild and severe anemia with acute HF severity and mortality. Data were prospectively collected for patients admitted to all departments of medicine an...
Inotrope use is one of the most controversial topics in the management of heart failure. While the heart failure community utilizes them and recognizes the state of inotrope dependency, retrospective analyses and registry data have overwhelmingly suggested high mortality, which is logically to ...
Heart failure (HF) is an increasingly important cause of morbidity and mortality. The annual incidence of HF in the U.S. has recently been estimated at 465,000 and is steadily rising, despite advances in medical therapy. Five-year survival rates are near 50% (1). Obesity is regarded as ...
Purpose of review: Describe the contemporary assessment of cardiac hemodynamics using a comprehensive echo-Doppler examination in the heart failure (HF) patient. Recent findings: Cardiac flow and filling pressures, on both the left and right sides of the heart, are fundamental to the accurate assess...
Background—Heart failure (HF) and atrial fibrillation (AF) share common risk factors and often coexist. The combination of HF and AF may carry a worse prognosis than either condition alone; however, the magnitude of this risk remains controversial and it is not known whether the timing of AF...
Cardiac magnetic resonance (CMR) is emerging as an important tool in the assessment of heart failure with preserved ejection fraction (HFpEF). This study sought to investigate the prognostic value of multiparametric CMR, including left and right heart vo
This study intends to predict in-hospital and 6-month mortality, as well as 30-day and 90-day hospital readmission, using Machine Learning (ML) approach via conventional features. A total of 737 patients remained after applying the exclusion criteria to 1101 heart failure patients. Thirty-four ...
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Heart Failure View LargeDownload Figure 1. Participant Flow in the TRANSFORM-HF Randomized Clinical Trial View LargeDownload For patients randomized twice, the second randomizations were completely removed from this diagram. ...
The harbinger of mortality in HFPEF: do GDF-15 levels reflect tandem, deterministic effects of fibrosis and inflammation? Putko BN,Yogasundaram H,Oudit GY.The harbinger of mortality in heart failure with preserved ejection fraction:do GDF-15 levels reflect tandem,deterministic effects of fibrosis ...